HELP Study - Towards High Throughput and Efficient Long-axial PET With Oral [18F]FDG

Typically, PET scans involve an IV injection of 18F-FDG that helps identify cancer. Patients are scanned 60 minutes after injecting 18F-FDG. This study aims to assess the feasibility of a different method of administration - oral ingestion (rather than IV) of 18F-FDG through delayed imaging to identify the optimal time for scanning after consuming the drug. The study will aim to recruit 15-24 individuals who will receive two PET scans - one using delayed oral 18F-FDG imaging and a second regular 18F-FDG. The analysis will focus on establishing a suitable protocol for this administration route while considering patient preference and image quality.

NCT Number	NCT07295171
Lead Sponsor	British Columbia Cancer Agency
Conditions	Multiple Cancers, Multiple Indications Cancer, Feasibility Studies
Enrollment	27 participants
Start Date	2026-02-18
Primary Completion	2026-12-15 (estimated)
Study Completion	2027-02-18 (estimated)
Updated on ClinicalTrials.gov	2026-03-31